Incivo 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - incivo, u kombinaciji sa peg interferonom alfa i ribavirinom, indiciran za liječenje genotip 1 kroničnog hepatitisa c kod odraslih pacijenata s компенсированным bolesti jetre (uključujući cirozu):koji je tretman naivan, koji je ranije liječenje interferonom alfa (пегилированным ili пегилированным) kao monoterapija ili u kombinaciji sa ribavirinom, uključujući i recidiv, djelomični okrivljenika i неответчики.

Zydelig 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Entresto 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, валсартан - zastoj srca - antagonisti angiotenzina ii, druge kombinacije, agenti koji djeluju na ренин-ангиотензиновую sustav - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, валсартан - zastoj srca - sredstva koja djeluju na sustav renin-angiotenzina - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Ciflox 2 mg/ml otopina za infuziju 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

ciflox 2 mg/ml otopina za infuziju

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - ciprofloxacinum - otopina za infuziju - 2 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 2 mg ciprofloksacina u obliku ciprofloksacinlaktata